First International Shipment of HANSIZHUANG
/PRNewswire/ -- On January 25, a truck carrying HANSIZHUANG Zerpidio® (anti-PD-1 monoclonal antibody, Chinese trade name: HANSIZHUANG) slowly left Henlius'...
Source: prnewswire.com
China Guidelines News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from China Guidelines. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In China Guidelines Today - Breaking & Trending Today
HANSIZHUANG Sets Sail in Indonesia Market - Thailand Business News
SHANGHAI, Dec. 28, 2023 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK) announces that recently, PT Kalbio Global Medika, the subsidiary of Henlius'
Source: thailand-business-news.com
The NDA for New Indication of Henlius Anti-PD-1 mAb Serplulimab in Combination with Chemotherapy for the First-line Treatment of non-squamous NSCLC Accepted by the NMPA
/PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK) announced that the NDA for new indication of HANSIZHUANG, serplulimab, an innovative anti-PD-1 mAb...
Source: prnewswire.com
Henlius Deepens Collaboration with Intas to bring Henlius' Novel anti-PD-1 mAb Serplulimab to Europe and India
/PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK) has entered into an exclusive license agreement with Intas Pharmaceuticals Limited ("Intas") for the...
Source: prnewswire.com
Henlius' Novel Anti-PD-1 mAb HANSIZHUANG (Serplulimab) Approved for the Treatment of ESCC
/PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696. HK) announced that the new drug application (NDA) for new indication of HANSIZHUANG (serplulimab...
Source: prnewswire.com